Nombre del producto:Sodium 2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetate

IUPAC Name:sodium 2-{[4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetate

CAS:1459687-96-7
Fórmula molecular:C16H13N4NaO3S
Pureza:98%
Número de catálogo:CM249535
Peso molecular:364.35

Unidad de embalaje Stock disponible Precio($) Cantidad
CM249535-10mg in stock ƻŔ
CM249535-25mg in stock ƞƞź
CM249535-50mg in stock ƞŔȀ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1459687-96-7
Fórmula molecular:C16H13N4NaO3S
Punto de fusión:-
Código de sonrisas:O=C([O-])CSC1=NN=C(C2=NC=CC=C2)N1C3=CC=CC(OC)=C3.[Na+]
Densidad:
Número de catálogo:CM249535
Peso molecular:364.35
Punto de ebullición:
Nº Mdl:
Almacenamiento:Store at 2-8°C.

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.